Mucormycosis is nearly 80 times more prevalent in India than the western countries, with 0.14 cases being reported per 1000 people. Therefore, clinicians must have a high index of suspicion for mucormycosis and identify the disease, especially in patients with high-risk factors. To discuss the latest guidelines for managing mucormycosis during the current pandemic for achieving better patient outcomes, Docplexus has organized a webinar by Dr.
Santosh Konda , where he will discuss “Mucormycosis - Epidemic Within the Pandemic” on 16 th November 2021, 3:00 PM onwards. Key points of discussion: How is mucormycosis caused and what are its effects? Clinicopathological aspects of mucormycosis Stay tuned for this exclusive session!
